These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

265 related items for PubMed ID: 18925509

  • 1. Lysophosphatidic acid-induced platelet shape change revealed through LPA(1-5) receptor-selective probes and albumin.
    Khandoga AL, Fujiwara Y, Goyal P, Pandey D, Tsukahara R, Bolen A, Guo H, Wilke N, Liu J, Valentine WJ, Durgam GG, Miller DD, Jiang G, Prestwich GD, Tigyi G, Siess W.
    Platelets; 2008 Sep; 19(6):415-27. PubMed ID: 18925509
    [Abstract] [Full Text] [Related]

  • 2. Subtype-selective antagonists of lysophosphatidic Acid receptors inhibit platelet activation triggered by the lipid core of atherosclerotic plaques.
    Rother E, Brandl R, Baker DL, Goyal P, Gebhard H, Tigyi G, Siess W.
    Circulation; 2003 Aug 12; 108(6):741-7. PubMed ID: 12885756
    [Abstract] [Full Text] [Related]

  • 3. Human platelets respond differentially to lysophosphatidic acids having a highly unsaturated fatty acyl group and alkyl ether-linked lysophosphatidic acids.
    Tokumura A, Sinomiya J, Kishimoto S, Tanaka T, Kogure K, Sugiura T, Satouchi K, Waku K, Fukuzawa K.
    Biochem J; 2002 Aug 01; 365(Pt 3):617-28. PubMed ID: 11982483
    [Abstract] [Full Text] [Related]

  • 4. Thrombogenic and atherogenic activities of lysophosphatidic acid.
    Siess W, Tigyi G.
    J Cell Biochem; 2004 Aug 15; 92(6):1086-94. PubMed ID: 15258894
    [Abstract] [Full Text] [Related]

  • 5. The plaque lipid lysophosphatidic acid stimulates platelet activation and platelet-monocyte aggregate formation in whole blood: involvement of P2Y1 and P2Y12 receptors.
    Haserück N, Erl W, Pandey D, Tigyi G, Ohlmann P, Ravanat C, Gachet C, Siess W.
    Blood; 2004 Apr 01; 103(7):2585-92. PubMed ID: 14645014
    [Abstract] [Full Text] [Related]

  • 6. Structure-activity analysis of the effects of lysophosphatidic acid on platelet aggregation.
    Gueguen G, Gaigé B, Grévy JM, Rogalle P, Bellan J, Wilson M, Klaébé A, Pont F, Simon MF, Chap H.
    Biochemistry; 1999 Jun 29; 38(26):8440-50. PubMed ID: 10387090
    [Abstract] [Full Text] [Related]

  • 7. Lysophosphatidic acid is the unique platelet-activating substance in human malignant ascites.
    Sandmann G, Siess W, Essler M.
    Eur J Med Res; 2003 Sep 29; 8(9):397-404. PubMed ID: 14555295
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Phosphorothioate analogues of alkyl lysophosphatidic acid as LPA3 receptor-selective agonists.
    Qian L, Xu Y, Simper T, Jiang G, Aoki J, Umezu-Goto M, Arai H, Yu S, Mills GB, Tsukahara R, Makarova N, Fujiwara Y, Tigyi G, Prestwich GD.
    ChemMedChem; 2006 Mar 29; 1(3):376-83. PubMed ID: 16892372
    [Abstract] [Full Text] [Related]

  • 11. Individual heterogeneity in platelet response to lysophosphatidic acid: evidence for a novel inhibitory pathway.
    Pamuklar Z, Lee JS, Cheng HY, Panchatcharam M, Steinhubl S, Morris AJ, Charnigo R, Smyth SS.
    Arterioscler Thromb Vasc Biol; 2008 Mar 29; 28(3):555-61. PubMed ID: 18202325
    [Abstract] [Full Text] [Related]

  • 12. Synthesis and pharmacological evaluation of second-generation phosphatidic acid derivatives as lysophosphatidic acid receptor ligands.
    Durgam GG, Tsukahara R, Makarova N, Walker MD, Fujiwara Y, Pigg KR, Baker DL, Sardar VM, Parrill AL, Tigyi G, Miller DD.
    Bioorg Med Chem Lett; 2006 Feb 29; 16(3):633-40. PubMed ID: 16263282
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Naturally occurring analogs of lysophosphatidic acid elicit different cellular responses through selective activation of multiple receptor subtypes.
    Fischer DJ, Liliom K, Guo Z, Nusser N, Virág T, Murakami-Murofushi K, Kobayashi S, Erickson JR, Sun G, Miller DD, Tigyi G.
    Mol Pharmacol; 1998 Dec 29; 54(6):979-88. PubMed ID: 9855625
    [Abstract] [Full Text] [Related]

  • 15. Selective non-lipid modulator of LPA5 activity in human platelets.
    Kozian DH, Evers A, Florian P, Wonerow P, Joho S, Nazare M.
    Bioorg Med Chem Lett; 2012 Aug 15; 22(16):5239-43. PubMed ID: 22801643
    [Abstract] [Full Text] [Related]

  • 16. Phosphonothioate and fluoromethylene phosphonate analogues of cyclic phosphatidic acid: Novel antagonists of lysophosphatidic acid receptors.
    Xu Y, Jiang G, Tsukahara R, Fujiwara Y, Tigyi G, Prestwich GD.
    J Med Chem; 2006 Aug 24; 49(17):5309-15. PubMed ID: 16913720
    [Abstract] [Full Text] [Related]

  • 17. Lysophosphatidic acids. Influence on platelet aggregation and intracellular calcium flux.
    Gerrard JM, Kindom SE, Peterson DA, Peller J, Krantz KE, White JG.
    Am J Pathol; 1979 Aug 24; 96(2):423-38. PubMed ID: 112871
    [Abstract] [Full Text] [Related]

  • 18. Synergistic activation of human platelets by lysophosphatidic acid and adrenaline.
    Nilsson U, Svensson SP, Grenegård M.
    Haematologica; 2002 Jul 24; 87(7):730-9; discussion 739. PubMed ID: 12091124
    [Abstract] [Full Text] [Related]

  • 19. Identification of Darmstoff analogs as selective agonists and antagonists of lysophosphatidic acid receptors.
    Gududuru V, Zeng K, Tsukahara R, Makarova N, Fujiwara Y, Pigg KR, Baker DL, Tigyi G, Miller DD.
    Bioorg Med Chem Lett; 2006 Jan 15; 16(2):451-6. PubMed ID: 16290140
    [Abstract] [Full Text] [Related]

  • 20. Cyclic phosphatidic acid and lysophosphatidic acid induce hyaluronic acid synthesis via CREB transcription factor regulation in human skin fibroblasts.
    Maeda-Sano K, Gotoh M, Morohoshi T, Someya T, Murofushi H, Murakami-Murofushi K.
    Biochim Biophys Acta; 2014 Sep 15; 1841(9):1256-63. PubMed ID: 24845645
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.